Karen F. Wilkinson

Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug

Michael M. Morgen, Corey Bloom, Ron Beyerinck et al. · Pharmaceutical Research · 2011 · 147 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Peptide to glycopeptide: glycosylated oligopeptide renin inhibitors with attenuated in vivo clearance properties

Jed F. Fisher, Allen W. Harrison, Gordon L. Bundy et al. · Journal of Medicinal Chemistry · 1991 · 101 citations

Medicine, Pharmacokinetics, Pharmacology +10

Structure-Based Design of HIV Protease Inhibitors:  Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors

Suvit Thaisrivongs, Harvey I. Skulnick, Steve R. Turner et al. · Journal of Medicinal Chemistry · 1996 · 96 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

The Integrated Value of Serum Procollagen Iii Peptide Over Time Predicts Hepatic Hydroxyproline Content and Stainable Collagen in A Model of Dietary Cirrhosis in the Rat

Mary J. Ruwart, Karen F. Wilkinson, Bob D. Rush et al. · Hepatology · 1989 · 95 citations

Medicine, Biochemistry, Pathology +17

Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesviruses

Roger J. Brideau, Mary L. Knechtel, Audris Huang et al. · Antiviral Research · 2002 · 78 citations

Medicine, Medicinal Chemistry, Pharmacology +11